Disrupting the Molecular Pathway in Myotonic Dystrophy |
| |
Authors: | Xiaomeng Xing Anjani Kumari Jake Brown John David Brook |
| |
Affiliation: | School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK; (X.X.); (A.K.); (J.B.) |
| |
Abstract: | Myotonic dystrophy is the most common muscular dystrophy in adults. It consists of two forms: type 1 (DM1) and type 2 (DM2). DM1 is associated with a trinucleotide repeat expansion mutation, which is transcribed but not translated into protein. The mutant RNA remains in the nucleus, which leads to a series of downstream abnormalities. DM1 is widely considered to be an RNA-based disorder. Thus, we consider three areas of the RNA pathway that may offer targeting opportunities to disrupt the production, stability, and degradation of the mutant RNA. |
| |
Keywords: | myotonic dystrophy CDK12 MBNL RAN translation molecular mechanism |
|
|